New PTSD drug shows promise in phase 3 trial
NCT ID NCT07456696
First seen Mar 07, 2026 · Last updated May 01, 2026 · Updated 10 times
Summary
This study tests whether a new drug called TSND-201 can safely reduce PTSD symptoms in adults. About 300 people with PTSD will receive either one of two doses of the drug or a placebo once a week for 4 weeks, then be followed for 8 more weeks. The goal is to see if the drug helps lower PTSD symptom severity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Accel Clinical Research
RECRUITINGMaitland, Florida, 32751, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Austin Clinical Trial Partners
RECRUITINGAustin, Texas, 78737, United States
Contact Phone: •••-•••-••••
-
Bio Behavioral Health
RECRUITINGToms River, New Jersey, 08755, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CNS Healthcare
RECRUITINGJacksonville, Florida, 32256, United States
Contact Phone: •••-•••-••••
-
CNS Healthcare
RECRUITINGOrlando, Florida, 32801, United States
Contact Email: •••••@•••••
-
CalNeuro Research Group
RECRUITINGLos Angeles, California, 90025, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Catalina Research Institute
RECRUITINGMontclair, California, 91763, United States
Contact Email: •••••@•••••
-
Global Medical Institutes
RECRUITINGPrinceton, New Jersey, 08540, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Haracec Clinical Research
RECRUITINGEl Paso, Texas, 79902, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Inland Psychiatric Medical Group
RECRUITINGSan Juan Capistrano, California, 92675, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Inner Space Research
RECRUITINGOrem, Utah, 84058, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Insight Clinical Trials
RECRUITINGIndependence, Ohio, 44131, United States
Contact Phone: •••-•••-••••
-
Midwest Research GRoup
RECRUITINGSaint Charles, Missouri, 63304, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Preferred Research Partners
RECRUITINGLittle Rock, Arkansas, 72211, United States
Contact Phone: •••-•••-••••
-
Segal Trials
RECRUITINGLauderhill, Florida, 33319, United States
Contact Email: •••••@•••••
-
Starlight Clinical Research
RECRUITINGEvergreen, Colorado, 80439, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Suburban Research Associates
RECRUITINGWest Chester, Pennsylvania, 19380, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Uptown Research Institute
RECRUITINGChicago, Illinois, 60640, United States
Contact Email: •••••@•••••
-
Vitalix Clinical
RECRUITINGWorcester, Massachusetts, 01608, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.